Priced like the old business, running like a new one: management is redirecting the call away from the metric investors
The model's full reasoning — Q2 2022 call → NOThe question asks whether management repeatedly redirects attention away from the conventional yardstick toward a different part of the business that is already earning today, and indicates the record hasn't caught up. Let me analyze the transcript carefully. The company is GoodRx, judged on prescription transactions revenue (the core business). The call is dominated by the grocer issue that hurt prescription transactions revenue. Key elements to check: 1. Does management identify the conventional yardstick and set it aside? 2. Does management put forward a different part of the business that is already earning? 3. Does management convey the record hasn't caught up? Looking at the transcript: - The conventional yardstick is prescription transactions revenue (the core business). - Management discusses the grocer issue extensively, which hurt prescription transactions. - Management highlights Pharma Manufacturer Solutions (PMS) revenue, which grew 102% year-over-year to $26.6 million. - Management also highlights subscriptions revenue, which grew 82% to $26 million. - Management notes "our other offerings now making up 30% of revenue compared to approximately 5% just three years ago." But does management SET ASIDE the conventional yardstick? Let me look... Management says: "We are disappointed with our performance this year" and discusses the grocer issue. They talk about prescription transactions revenue decreasing 7%. They don't really say "prescription transactions is no longer the right thing to watch." Instead, they discuss the grocer issue as a temporary problem and talk about fixing it. The diversification point: "The diversification of our revenue continued in the second quarter with our other offerings now making up 30% of revenue compared to approximately 5% just three years ago, primarily driven by their rapid growth." But this is presented as diversification, not as setting aside the conventional yardstick. Management still organizes the call around prescription transactions revenue, the grocer issue, and guidance for the overall business. Management does highlight Pharma Manufacturer Solutions as growing strongly and describes it as already earning (102% growth, $26.6 million revenue). But does management say the record hasn't caught up? Not really - the PMS revenue is already in the reported figures.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| LOB | Live Oak Bancshares, Inc. | Q3 2018 | 2018-10-25 | C+ |
SPT · Q2 2023 → YESThe question is whether management repeatedly redirects attention away from the conventional measure toward a different part of the business that's already earning today, and indicates that this diffe...YES The transcript shows management repeatedly reframing away from the conventional total ARR/revenue growth metric (which is being distorted by unpredictable low-end non-core ARR) toward the higher-quality up-market/enterprise segment that is already delivering record new business ACVs, 50%+ YoY growth, and 43% of 2023 ARR. They explicitly set the low-end aside by removing it from forecasts and modeling to give “greatest visibility,” note that Q2 ARR growth will be the lowest pace of the year because of this change, and indicate the reported figures still reflect the old mix while the new up-market story is already earning today (with Tagger adding further upside not yet reflected). This creates the coherent posture of redirecting attention from the headline growth number outsiders watch to the part of the business that is already producing real results.
WD · Q2 2022 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly reframing the discussion away from the conventional multifamily agency lender yardstick (origination volumes, GSE lending, MSR-driven EPS) toward the diversified services and asset-management businesses that are already generating substantial cash revenue and EBITDA today. They explicitly set the old metric aside by introducing adjusted EPS to “strip out non-cash mortgage servicing rights,” highlight the shift from “lending-centric” to “broader technology-enabled financial services,” and note that segment results now provide “more transparency into our operating structure.” They point to debt brokerage, property sales, SAM (Alliant, Zelman), small-balance lending, and appraisals as the new earning engines, describing their concrete contributions (e.g.
CALX · Q1 2023 → YESThe question is about whether management repeatedly redirects attention away from the conventional measure to a different part of the business that's already earning today, and indicates that this isn...YES The transcript shows management repeatedly framing the company as operating in a "new market" centered on platforms, clouds, and managed services—distinct from the legacy hardware/cyclical model—while highlighting real earnings from these areas (e.g., 988 BSPs deploying platforms, 865 cloud customers, 334 with 41 new managed services in Q1, record Intelligent Access EDGE revenue). They indicate this is already producing revenue and customer adoption but remains early-stage ("this is the beginning," "early stage of where we are in this new market"), with reported results still reflecting the prior hardware-focused picture.